Navigation Links
Measuring the uncertainties of pandemic influenza
Date:7/2/2012

A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.

Researchers from Argonne, Los Alamos, and Sandia National Laboratories, and the National Renewable Energy Laboratory, have used sensitivity analysis to uncover the most important disease characteristics pertaining to the spread of infection with an influenza virus. These are: the fraction of the transmission that occurs prior to symptoms, the reproductive number, and the length of each disease stage. Their use of data from past pandemics as well as information on potential viral evolution demonstrates that current response planning may underestimate the pandemic consequences significantly.

"It has become critical to assess the potential range of consequences of a pandemic influenza outbreak given the uncertainty about its disease characteristics while investigating risks and mitigation strategies of vaccines, antiviral drugs, and social distancing measures," explains Jeanne Fair of Los Alamos National Laboratory and her colleagues. The team has used a simulation model and rigorous experimental design with sensitivity analysis to show the extremes of consequences of a potential pandemic outbreak in the USA. The simulation incorporates uncertainty in the evolution and characteristics of the pathogen and differences in the epidemic response, and uncertainties in the sociological response to a pandemic.

Although we are yet to face an H5N1 avian influenza epidemic, the team suggests that they have nevertheless been able to develop a worst-case scenario for all possibilities considering mortality rates and infectiousness based on current knowledge and historical patterns dating back to the 1917-1918 global pandemic. They suggest that a future worst-case influenza pandemic might be up to four times as lethal as the pandemic that occurred towards the end of the Great War. Moreover, their simulation suggests that the use of antiviral drugs may not be as effective as healthcare authorities would hope. On a positive note, they have found that social distancing could be the most effective way to contain the spread of infection, usefully reducing symptoms by an average of 16% although it will cost 50% more than antiviral use through lost working days and commerce.

"Do we prepare for the worst-case scenario when preparing for a pandemic?" asks Fair. "While the worst-case scenario is indeed the worst, it may not be as likely. As far as mortality rates, the 1918 was the worst but really still was only around 2% which is could be considered low." While, the next pandemic could be worse than that of 1917-1918, the worst case scenario may not be as likely, the team concludes. Their study supports earlier findings that no single, pure strategy is best and that a mix of pharmaceutical and non-pharmaceutical interventions will be needed to contain the disease and reduce the total number of deaths. It would be prudent to incorporate these findings in planning for the next pandemic, the team asserts.


'/>"/>

Contact: Jeanne M. Fair
jmfair@lanl.gov
Inderscience Publishers
Source:Eurekalert

Related medicine news :

1. Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real
2. Pandemic H1N1 Flu Killed Far More Than Reported: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , ... July 26, 2017 , ... An inventor from ... and I haven’t yet seen an effective and dignified way to keep leeches in ... the LEECH CUP." , This invention provides an effective way to keep a leech ...
(Date:7/26/2017)... Ca (PRWEB) , ... July 26, 2017 , ... A ... lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry cycle are ... webinar will discuss freeze drying techniques, as well as new accessories and advancements in ...
(Date:7/26/2017)... ... July 26, 2017 , ... GTB ... cloud ; today announced the availability of its latest data protection solution Crypt-n-Chive. ... control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB Crypt-n-Chive ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and ... from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... “Now Hiring!” ... St. Louis, Missouri. The company has achieved record-breaking sales for over 30 consecutive ... the next 12 months. , The upcoming year offers excitement and growth at HDIS, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... 2017 The Institute for In Vitro Sciences ... recipient of a VITROCELL® inhalation exposure system thanks to ... The device, which is designed to replace animals in ... cells to airborne test materials in an environment that ... system for testing combustible tobacco products, as well as ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology: